A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010

Methodology for determining major constituents of ayahuasca and their metabolites in blood

(2011) Ethan H. McIlhenny et al.   BIOMEDICAL CHROMATOGRAPHY

Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions

(2011) Hong-Wu Shen et al.   CURRENT DRUG METABOLISM

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine

(2010) Ethan H. McIlhenny et al.   BIOMEDICAL CHROMATOGRAPHY

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter

(2009) Nicholas V. Cozzi et al.   JOURNAL OF NEURAL TRANSMISSION

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

(2009) J. Daumann et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator

(2009) D. Fontanilla et al.   SCIENCE

When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor

(2009) T.-P. Su et al.   Science Signaling

Halogenated solvent interactions with N,N-dimethyltryptamine: Formation of quaternary ammonium salts and their artificially induced rearrangements during analysis

(2008) Simon D. Brandt et al.   FORENSIC SCIENCE INTERNATIONAL